Successful treatment with amoxicillin-clavulanic acid: cutaneous nocardiosis caused by Nocardia brasiliensis

References

• Margalit I, Lebeaux D, Tishler O, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021;27(4):1–4. doi:10.1016/j.cmi.2020.12.019.
   PubMed Web of Science ®Google Scholar
• Lv H, Chen M, Ji Y, et al. A rare case of a subcutaneous abscess caused by Nocardia cyriacigeorgica in an immunocompetent patient. Infect Drug Resist. 2023;16:263–268. doi:10.2147/IDR.S395333.
   PubMed Web of Science ®Google Scholar
• Toyokawa M, Ohana N, Ueda A, et al. Identification and antimicrobial susceptibility profiles of nocardia species clinically isolated in Japan. Sci Rep. 2021;11(1):16742. doi:10.1038/s41598-021-95870-2.
   PubMed Web of Science ®Google Scholar
• Yi M, Wang L, Xu W, et al. Species distribution and antibiotic susceptibility of Nocardia isolates from Yantai, China. Infect Drug Resist. 2019;12:3653–3661. doi:10.2147/IDR.S232098.
   PubMed Web of Science ®Google Scholar
• Berges Gimeno MP, Bernal Rubio L, Roldán E, et al. Positive basophil activation test result in a patient with anaphylaxis to cotrimoxazole. J Investig Allergol Clin Immunol. 2022;32(5):410–412. doi:10.18176/jiaci.0778.
   PubMed Web of Science ®Google Scholar
• Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106(4):459–465. doi:10.1016/s0002-9343(99)00041-8.
   PubMed Web of Science ®Google Scholar
• Jahncke A, Kay V, Fiore B. Tattoo trouble: a case of drug-induced thrombocytopenic purpura. Mil Med. 2022;187(5–6):e778–e780. doi:10.1093/milmed/usab068.
   PubMed Web of Science ®Google Scholar
• Lin J, Ding J, Di X, et al. Association between prenatal antibiotics exposure and measures of fetal growth: a repeated-measure study. Ecotoxicol Environ Saf. 2022;244:114041. doi:10.1016/j.ecoenv.2022.114041.
   PubMed Web of Science ®Google Scholar
• Hamdi AM, Fida M, Deml SM, et al. Retrospective analysis of antimicrobial susceptibility profiles of nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020;64(3):e01868-19. doi:10.1128/AAC.01868-19.
   PubMed Web of Science ®Google Scholar
• Engelbrecht A, Saad H, Gross H, et al. Natural products from nocardia and their role in pathogenicity. Microb Physiol. 2021;31(3):217–232. doi:10.1159/000516864.
   PubMedGoogle Scholar
• Lebeaux D, Freund R, van Delden C, et al. Outcome and treatment of nocardiosis after solid organ transplantation: new insights from a European study. Clin Infect Dis. 2017;64(10):1396–1405. doi:10.1093/cid/cix124.
   PubMed Web of Science ®Google Scholar
• Fujita T, Ikari J, Watanabe A, et al. Clinical characteristics of pulmonary nocardiosis in immunocompetent patients. J Infect Chemother. 2016;22(11):738–743. doi:10.1016/j.jiac.2016.08.004.
   PubMed Web of Science ®Google Scholar
• JW,Wilson. Nocardiosis: updates and clinical overview. Mayo Clin Proc. 2012;87(4):403–407. doi:10.1016/j.mayocp.2011.11.016.
   PubMed Web of Science ®Google Scholar
• Li S, Ji B, Teng Y, et al. Erythema nodosum following nocardia infection: a case report. Medicina. 2022;58(12):1873. doi:10.3390/medicina58121873.
   PubMedGoogle Scholar
• Camozzota C, Goldman A, Tchernev G, et al. A primary cutaneous nocardiosis of the hand. Open Access Maced J Med Sci. 2017;5(4):470–472. doi:10.3889/oamjms.2017.106.
   PubMedGoogle Scholar
• Ramos-E-Silva M, Lopes RS, Trope BM. Cutaneous nocardiosis: a great imitator. Clin Dermatol. 2020;38(2):152–159. doi:10.1016/j.clindermatol.2019.10.009.
   PubMed Web of Science ®Google Scholar
• Secchin P, Trope BM, Fernandes LA, et al. Cutaneous nocardiosis simulating cutaneous lymphatic sporotrichosis. Case Rep Dermatol. 2017;9(2):119–129. doi:10.1159/000471788.
   PubMedGoogle Scholar
• Lao CK, Tseng MC, Chiu CH, et al. Clinical manifestations and antimicrobial susceptibility of nocardia species at a tertiary hospital in Taiwan, 2011–2020. J Formos Med Assoc. 2022;121(10):2109–2122. doi:10.1016/j.jfma.2022.06.011.
   PubMed Web of Science ®Google Scholar
• Barry M, AlShehri S, Alguhani A, et al. A fatal case of disseminated nocardiosis due to Nocardia otitidiscaviarum resistant to trimethoprim-sulfamethoxazole: case report and literature review. Ann Clin Microbiol Antimicrob. 2022;21(1):17. doi:10.1186/s12941-022-00511-9.
   PubMed Web of Science ®Google Scholar
• Tan YE, Chen SC, Halliday CL. Antimicrobial susceptibility profiles and species distribution of medically relevant nocardia species: results from a large tertiary laboratory in Australia. J Glob Antimicrob Resist. 2020;20:110–117. doi:10.1016/j.jgar.2019.06.018.
   PubMed Web of Science ®Google Scholar
• Davidson N, Grigg MJ, Mcguinness SL, et al. Safety and outcomes of linezolid use for nocardiosis. Open Forum Infect Dis. 2020;7(4):ofaa090.
   PubMed Web of Science ®Google Scholar
• Sim BZ, Aaron L, Coulter C, et al. A multi-Centre retrospective study of nocardia speciation and antimicrobial susceptibility in Queensland, Australia. Eur J Clin Microbiol Infect Dis. 2023;42(3):339–345. doi:10.1007/s10096-022-04542-0.
   PubMed Web of Science ®Google Scholar
• Yang J, Ren HT, Wang J, et al. Clinical characteristics, susceptibility profiles, and treatment of nocardiosis: a multicenter retrospective study in 2015-2021. Int J Infect Dis. 2023;130:136–143. doi:10.1016/j.ijid.2023.02.023.
   PubMed Web of Science ®Google Scholar
• Ambrosioni J, Lew D, Garbino J. Nocardiosis: updated clinical review and experience at a tertiary center. Infection. 2010;38(2):89–97. doi:10.1007/s15010-009-9193-9.
   PubMed Web of Science ®Google Scholar
• Restrepo A, Clark NM. Nocardia infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American society of transplantation. Clin Transplant. 2019;33(9):e13509. doi:10.1111/ctr.13509.
   PubMedGoogle Scholar